Kyle Faget, Of Counsel in the firm’s Health Care and Telemedicine Industry Team and Digital Health Industry Team, will be a speaker at the Dynamic Global Events’ Clinical Trial Agreements Conference on Monday, January 25th at 11:45 AM ET. She will be part of the panel titled, “Negotiate for the Use of Biospecimens Outside of the Trial.”
When one clinical trial concludes, another begins. There can be occasions in which biospecimens remain from a previous trial that are a fit for the next. Prior to their use, sponsors must include the proper language in multiple agreements with participants to avoid any type of fiscal penalties. This session explores what must be agreed upon prior to additional uses of these biospecimens.
- Review HIPAA privacy rules surrounding biospecimens
- Fold biospecimen rights into informed consent documentation
- Center the confidentiality of identifiable protected health information
To learn more and register for the conference, click here.
